Bristol Myers Squibb Cash Flow Statement

BMY / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)

Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.

Bristol Myers Squibb generated $14.2B in operating cash flow and $12.8B in free cash flow in FY2025. Free cash flow margin was 26.7% of revenue.

Based on SEC 10-K filings.

Key Data Points

High Piotroski F-Score: 8/9 (strong financial health signals)
Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
High earnings quality (cash-backed earnings)
Strong return on equity: 32.6%

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Net Income	$7.1B	-$8.9B	$8.0B	$6.3B	$7.0B	-$9.0B	$1.0B	$4.5B	$1.0B	$2.0B	$2.6B	$2.0B	$3.7B	$3.1B	$3.7B
Depreciation & Amortization	$4.0B	$9.6B	$9.8B	$10.3B	$10.7B	$10.4B	$789.0M	$382.0M	$789.0M	$467.0M	$763.0M	$467.0M	$628.0M	$607.0M	$628.0M
Operating Cash Flow	$14.2B	$15.2B	$13.9B	$13.1B	$16.2B	$14.1B	$5.3B	$3.1B	$5.3B	$3.1B	$3.5B	$3.1B	$4.8B	$4.5B	$4.8B
Capital Expenditures	$1.3B	$1.2B	$1.2B	$1.1B	$973.0M	$753.0M	$1.1B	$1.2B	$1.1B	$526.0M	$537.0M	$526.0M	$367.0M	$424.0M	$367.0M
Free Cash Flow	$12.8B	$13.9B	$12.7B	$11.9B	$15.2B	$13.3B	$4.2B	$1.8B	$4.2B	$2.6B	$3.0B	$2.6B	$4.5B	$4.1B	$4.5B
Share Buybacks	$0	$0	$5.2B	$8.0B	$6.3B	$1.5B	$2.5B	$231.0M	$2.5B	$231.0M	$433.0M	-	$1.2B	$576.0M	$1.2B
Dividends Paid	$5.0B	$4.9B	$4.7B	$4.6B	$4.4B	$4.1B	$2.6B	$2.5B	$2.6B	$2.4B	$2.3B	$2.4B	$2.3B	$2.2B	$2.3B
FCF Margin	26.7%	28.9%	28.1%	25.9%	32.8%	31.3%	20.3%	9.5%	20.3%	16.5%	18.4%	16.5%	21.1%	20.9%	21.1%

Other Financial Statements

Income Statement Balance Sheet All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Bristol Myers Squibb Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

Net Income

$7.1B

-$8.9B

$8.0B

$6.3B

$7.0B

-$9.0B

$1.0B

$4.5B

$1.0B

$2.0B

$2.6B

$2.0B

$3.7B

$3.1B

$3.7B

Depreciation & Amortization

$4.0B

$9.6B

$9.8B

$10.3B

$10.7B

$10.4B

$789.0M

$382.0M

$789.0M

$467.0M

$763.0M

$467.0M

$628.0M

$607.0M

$628.0M

Operating Cash Flow

$14.2B

$15.2B

$13.9B

$13.1B

$16.2B

$14.1B

$5.3B

$3.1B

$5.3B

$3.1B

$3.5B

$3.1B

$4.8B

$4.5B

$4.8B

Capital Expenditures

$1.3B

$1.2B

$1.1B

$973.0M

$753.0M

$1.1B

$1.2B

$1.1B

$526.0M

$537.0M

$526.0M

$367.0M

$424.0M

$367.0M

Free Cash Flow

$12.8B

$13.9B

$12.7B

$11.9B

$15.2B

$13.3B

$4.2B

$1.8B

$4.2B

$2.6B

$3.0B

$2.6B

$4.5B

$4.1B

$4.5B

Share Buybacks

$5.2B

$8.0B

$6.3B

$1.5B

$2.5B

$231.0M

$2.5B

$231.0M

$433.0M

$1.2B

$576.0M

$1.2B

Dividends Paid

$5.0B

$4.9B

$4.7B

$4.6B

$4.4B

$4.1B

$2.6B

$2.5B

$2.6B

$2.4B

$2.3B

$2.4B

$2.3B

$2.2B

$2.3B

FCF Margin

26.7%

28.9%

28.1%

25.9%

32.8%

31.3%

20.3%

9.5%

20.3%

16.5%

18.4%

16.5%

21.1%

20.9%

21.1%